BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20600126)

  • 1. Interactions of the melanocortin-4 receptor with the peptide agonist NDP-MSH.
    Chapman KL; Kinsella GK; Cox A; Donnelly D; Findlay JB
    J Mol Biol; 2010 Aug; 401(3):433-50. PubMed ID: 20600126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
    Yang Y; Chen M; Ventro G; Harmon CM
    Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
    Fleck BA; Ling N; Chen C
    Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.
    Haskell-Luevano C; Cone RD; Monck EK; Wan YP
    Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of ligand binding to the human melanocortin-4 receptor.
    Yang YK; Fong TM; Dickinson CJ; Mao C; Li JY; Tota MR; Mosley R; Van Der Ploeg LH; Gantz I
    Biochemistry; 2000 Dec; 39(48):14900-11. PubMed ID: 11101306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
    Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
    J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of the intracellular segments of the melanocortin-4 receptor for NDP-MSH signaling.
    Yang Y; Chen M; Loux TJ; Georgeson KE; Harmon CM
    Biochemistry; 2005 May; 44(18):6971-9. PubMed ID: 15865442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
    Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of the conserved amino acids of the melanocortin-4 receptor in [corrected] [Nle4,D-Phe7]-alpha-melanocyte-stimulating [corrected] hormone binding and signaling.
    Chen M; Cai M; Aprahamian CJ; Georgeson KE; Hruby V; Harmon CM; Yang Y
    J Biol Chem; 2007 Jul; 282(30):21712-9. PubMed ID: 17545153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insight into the MC4R conformational changes via different agonist-mediated receptor signaling.
    Yang Y; Chen M; Dimmitt R; Harmon CM
    Biochemistry; 2014 Nov; 53(45):7086-92. PubMed ID: 25347793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning, tissue distribution, and pharmacological characterization of melanocortin-4 receptor in spotted scat, Scatophagus argus.
    Li JT; Yang Z; Chen HP; Zhu CH; Deng SP; Li GL; Tao YX
    Gen Comp Endocrinol; 2016 May; 230-231():143-52. PubMed ID: 27080551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression in hypothalamus, liver, and adipose tissues and food intake response to melanocortin-4 receptor agonist in pigs expressing melanocortin-4 receptor mutations.
    Barb CR; Hausman GJ; Rekaya R; Lents CA; Lkhagvadorj S; Qu L; Cai W; Couture OP; Anderson LL; Dekkers JC; Tuggle CK
    Physiol Genomics; 2010 May; 41(3):254-68. PubMed ID: 20215418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-dependent internalization of the human melanocortin-4 receptors in human embryonic kidney 293 cells.
    Gao Z; Lei D; Welch J; Le K; Lin J; Leng S; Duhl D
    J Pharmacol Exp Ther; 2003 Dec; 307(3):870-7. PubMed ID: 14534363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.
    Pogozheva ID; Chai BX; Lomize AL; Fong TM; Weinberg DH; Nargund RP; Mulholland MW; Gantz I; Mosberg HI
    Biochemistry; 2005 Aug; 44(34):11329-41. PubMed ID: 16114870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Macrocyclic Agouti-Related Protein/[Nle
    Ericson MD; Freeman KT; Schnell SM; Haskell-Luevano C
    J Med Chem; 2017 Jan; 60(2):805-813. PubMed ID: 28045525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
    Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
    J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of melanocortin-4 receptor agonists and antagonists on expression of genes related to reproduction in spotted scat, Scatophagus argus.
    Jiang DN; Li JT; Tao YX; Chen HP; Deng SP; Zhu CH; Li GL
    J Comp Physiol B; 2017 May; 187(4):603-612. PubMed ID: 28197776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
    Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
    Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.